Philipp Sievers

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications

Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration.

Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration.

Journal: Neuro-oncology advances
Published: April 27, 2026

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Journal: Neuropathology and applied neurobiology
Published: April 20, 2026

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Journal: Acta neuropathologica
Published: February 21, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications
Published: January 09, 2026

PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology.

PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology.

Journal: bioRxiv : the preprint server for biology
Published: January 07, 2026

Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas.

Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas.

Journal: Acta neuropathologica communications
Published: December 23, 2025

MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma.

MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma.

Journal: Acta neuropathologica communications
Published: December 06, 2025

Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion.

Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion.

Journal: The oncologist
Published: October 09, 2025

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

Journal: Nature communications
Published: October 09, 2025

Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings.

Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings.

Journal: Virchows Archiv : an international journal of pathology
Published: October 02, 2025

A Cre-mediated copy number variant compromises the reliability of a LoxP-STOP-LoxP-PLAG1 driven brain tumor model.

A Cre-mediated copy number variant compromises the reliability of a LoxP-STOP-LoxP-PLAG1 driven brain tumor model.

Journal: Neuro-oncology advances
Published: September 03, 2025

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.

Journal: Acta neuropathologica communications
Published: August 21, 2025
Showing 1-12 of 123

Last Updated: 09/26/2026